Sartorius Stedim Bio (SDMHF) 275.0000 $SDMHF
David Newble Joins TTP Labtech as New Managing Director
Business Wire - Thu Jun 18, 8:00AM CDT
TTP Labtech, a world leader in the design and development of automated instrumentation and consumables for life science applications, is pleased to announce the appointment of David Newble as its new managing director. Dr. Jas Sangera, founder, managing director and key driver for the company for the last 14 years, will continue his role as the company's chairman.
Top 100 Recently Improved Medical Devices/Technology/Supplies Companies 2015 - News, financial/non-financial information and stock market analysis
M2 - Tue Mar 24, 7:40AM CDT
Research and Markets (http://www.researchandmarkets.com/research/wq6xl5/global_recently) has announced the addition of the "Global Recently Improved Medical Devices/Technology/Supplies 100 - An Industry Report" report to their offering. This newly launched report identifies 100 Recently Improved medical devices/technology/supplies companies globally and covers various aspects of these 100 companies including news, financial/non-financial information and stock market analysis. As price pressures increase, medical device makers need to rethink product development processes. Design to Value can help get costs under control and deliver exactly what customers value. The sector has always been challenging, with increasingly complex technologies and tough quality and regulatory hurdles. Until recently, however, device makers who overcame those barriers could sell their products at prices that made the effort worthwhile. Today, medical device companies operate in a different world. In developed countries, healthcare systems are under acute financial pressure. Healthcare providers are responding by exploring every opportunity to increase efficiencies and reduce costs. Developing economies are transforming the environment, too. As growth slows in established markets, opportunities are arising elsewhere. A rapidly growing middle class is demanding more medical devices of all types, but price sensitivity in these markets is acute. Report Highlights: - Global Recently Improved 100 medical devices/technology/supplies companies - Integration of company news and industry news, as well as rankings and stock market performances - Important M&A and alliances of Global Recently Improved medical devices/technology/supplies companies with foreign companies - International presence of Global Recently Improved medical devices/technology/supplies companies - Key R&D activities by Global Recently Improved medical devices/technology/supplies companies Companies Mentioned (Partial List) - Aigan Co., Ltd. (Japan) - Alterola Biotech, Inc. (United States) - Ambu A/S (Denmark) - Amedica Corp (United States) - Delcath Systems Incorporated (United States) - Dexcom, Inc. (United States) - Ginko International Co Ltd (Taiwan) - Gruppo Luxottica S.p.A. (Italy) - Karolinska Development AB (Sweden) - Lumenis Ltd (United States) - Newmax Technology Company Limited (Taiwan) - Nolato AB (Sweden) - Ohara Inc (Japan) - Sartorius Stedim Biotech Sa (France) - Straumann Holding AG (Switzerland) - Varian Medical Systems, Inc. (United States) - VWR Corp (United States) - Zeltiq Aesthetics Inc (United States) - ZoomMed Inc. (Canada) For more information visit http://www.researchandmarkets.com/research/wq...l_recently
ZLTQ: 28.07 (+0.59), VWR: 25.43 (-0.23), VAR: 86.80 (+1.82), LMNS: 13.74 (+0.13), DCTH: 0.84 (unch), AMDA: 0.62 (+0.09)
Research and Markets: Global Single-Use Bio-Processing Systems Market 2014-2018 With GE Healthcare, Merck & Co, Sartorius Stedim Biotech & ThermoFisher Scientific Dominating
Business Wire - Thu Jul 17, 5:36AM CDT
Research and Markets (http://www.researchandmarkets.com/research/twp8ts/global_singleuse) has announced the addition of the "Global Single-use Bio-processing Systems Market 2014-2018 with GE Healthcare, Merck & Co, Sartorius Stedim Biotech & ThermoFisher Scientific Dominating" report to their offering.
Global Single-use Bio-processing Systems Market 2014-2018 with GE Healthcare, Merck & Co, Sartorius Stedim Biotech & ThermoFisher Scientific Dominating
M2 - Thu Jul 17, 5:02AM CDT
Research and Markets (http://www.researchandmarkets.com/research/dkzwqv/global_singleuse) has announced the addition of the "Global Single-use Bio-processing Systems Market 2014-2018 with GE Healthcare, Merck & Co, Sartorius Stedim Biotech & ThermoFisher Scientific Dominating" report to their offering. The Global Single-use Bio-processing Systems market will grow at a CAGR of 38% to 2018 The report discusses the major drivers that influence the growth of the market. It also outlines the challenges faced by the vendors and the market at large, as well as the key trends that are emerging in the market. Owing to the growing potential of the Global Single-use Bio-processing Systems market, many bio-processing systems manufacturers collaborate to develop new platforms for the cultivation of cells or to develop new systems. For example, Sartorius's collaboration with Refine Technology LLC for the development of a robust platform for high-density cell cultivation. This platform will enable fast and easy connection of the alternating tangential flow system to Sartorius Stedim Biotech's field-proven single-use BIOSTAT bioreactors. Moreover, the partnership would enable the development of new designs of clinical analyzers and enable vendors to stay competitive in the market. This in turn could boost the growth of the Global Single-use Bio-processing Systems market. According to the report, the increasing demand for biopharmaceuticals is one of the major drivers in this market. The aging population in the US is expected to double and reach a total of 71 million by 2030. Cardiovascular diseases, Alzheimer's, and cancer are some of the most common diseases seen in the aged. Therefore, the steadily growing aging population increases the prevalence of these diseases, which in turn increases the demand for biopharmaceuticals. Further, the report states that the implementation of stringent regulations is one of the major challenges faced by the vendors in this market. Currently, the regulations for single-use bio-processing systems are not completely defined and documented, because the FDA has been quite liberal in not imposing more stringent regulations. However, the regulations are still uncertain owing to the limited usage of single-use bio-processing systems in commercial production. Key Vendors - GE Healthcare - Merck & Co Inc. - Sartorius Stedim Biotech SA - ThermoFisher Scientific Inc. Key Topics Covered: - Executive Summary - List of Abbreviations - Scope of the Report - Market Research Methodology - Introduction - Market Landscape - Market Segmentation by Applications - Geographical Segmentation - Buying Criteria - Market Growth Drivers - Drivers and their Impact - Market Challenges - Impact of Drivers and Challenges - Market Trends - Trends and their Impact - Vendor Landscape - Key Vendor Analysis For more information visit http://www.researchandmarkets.com/research/dk..._singleuse
MRK: 57.95 (+0.57)
David Newble Joins TTP Labtech as New Managing Director
Business Wire - Thu Jun 18, 8:00AM CDT
TTP Labtech, a world leader in the design and development of automated instrumentation and consumables for life science applications, is pleased to announce the appointment of David Newble as its new managing director. Dr. Jas Sangera, founder, managing director and key driver for the company for the last 14 years, will continue his role as the company's chairman.
Top 100 Recently Improved Medical Devices/Technology/Supplies Companies 2015 - News, financial/non-financial information and stock market analysis
M2 - Tue Mar 24, 7:40AM CDT
Research and Markets (http://www.researchandmarkets.com/research/wq6xl5/global_recently) has announced the addition of the "Global Recently Improved Medical Devices/Technology/Supplies 100 - An Industry Report" report to their offering. This newly launched report identifies 100 Recently Improved medical devices/technology/supplies companies globally and covers various aspects of these 100 companies including news, financial/non-financial information and stock market analysis. As price pressures increase, medical device makers need to rethink product development processes. Design to Value can help get costs under control and deliver exactly what customers value. The sector has always been challenging, with increasingly complex technologies and tough quality and regulatory hurdles. Until recently, however, device makers who overcame those barriers could sell their products at prices that made the effort worthwhile. Today, medical device companies operate in a different world. In developed countries, healthcare systems are under acute financial pressure. Healthcare providers are responding by exploring every opportunity to increase efficiencies and reduce costs. Developing economies are transforming the environment, too. As growth slows in established markets, opportunities are arising elsewhere. A rapidly growing middle class is demanding more medical devices of all types, but price sensitivity in these markets is acute. Report Highlights: - Global Recently Improved 100 medical devices/technology/supplies companies - Integration of company news and industry news, as well as rankings and stock market performances - Important M&A and alliances of Global Recently Improved medical devices/technology/supplies companies with foreign companies - International presence of Global Recently Improved medical devices/technology/supplies companies - Key R&D activities by Global Recently Improved medical devices/technology/supplies companies Companies Mentioned (Partial List) - Aigan Co., Ltd. (Japan) - Alterola Biotech, Inc. (United States) - Ambu A/S (Denmark) - Amedica Corp (United States) - Delcath Systems Incorporated (United States) - Dexcom, Inc. (United States) - Ginko International Co Ltd (Taiwan) - Gruppo Luxottica S.p.A. (Italy) - Karolinska Development AB (Sweden) - Lumenis Ltd (United States) - Newmax Technology Company Limited (Taiwan) - Nolato AB (Sweden) - Ohara Inc (Japan) - Sartorius Stedim Biotech Sa (France) - Straumann Holding AG (Switzerland) - Varian Medical Systems, Inc. (United States) - VWR Corp (United States) - Zeltiq Aesthetics Inc (United States) - ZoomMed Inc. (Canada) For more information visit http://www.researchandmarkets.com/research/wq...l_recently
ZLTQ: 28.07 (+0.59), VWR: 25.43 (-0.23), VAR: 86.80 (+1.82), LMNS: 13.74 (+0.13), DCTH: 0.84 (unch), AMDA: 0.62 (+0.09)
Research and Markets: Global Single-Use Bio-Processing Systems Market 2014-2018 With GE Healthcare, Merck & Co, Sartorius Stedim Biotech & ThermoFisher Scientific Dominating
Business Wire - Thu Jul 17, 5:36AM CDT
Research and Markets (http://www.researchandmarkets.com/research/twp8ts/global_singleuse) has announced the addition of the "Global Single-use Bio-processing Systems Market 2014-2018 with GE Healthcare, Merck & Co, Sartorius Stedim Biotech & ThermoFisher Scientific Dominating" report to their offering.
Global Single-use Bio-processing Systems Market 2014-2018 with GE Healthcare, Merck & Co, Sartorius Stedim Biotech & ThermoFisher Scientific Dominating
M2 - Thu Jul 17, 5:02AM CDT
Research and Markets (http://www.researchandmarkets.com/research/dkzwqv/global_singleuse) has announced the addition of the "Global Single-use Bio-processing Systems Market 2014-2018 with GE Healthcare, Merck & Co, Sartorius Stedim Biotech & ThermoFisher Scientific Dominating" report to their offering. The Global Single-use Bio-processing Systems market will grow at a CAGR of 38% to 2018 The report discusses the major drivers that influence the growth of the market. It also outlines the challenges faced by the vendors and the market at large, as well as the key trends that are emerging in the market. Owing to the growing potential of the Global Single-use Bio-processing Systems market, many bio-processing systems manufacturers collaborate to develop new platforms for the cultivation of cells or to develop new systems. For example, Sartorius's collaboration with Refine Technology LLC for the development of a robust platform for high-density cell cultivation. This platform will enable fast and easy connection of the alternating tangential flow system to Sartorius Stedim Biotech's field-proven single-use BIOSTAT bioreactors. Moreover, the partnership would enable the development of new designs of clinical analyzers and enable vendors to stay competitive in the market. This in turn could boost the growth of the Global Single-use Bio-processing Systems market. According to the report, the increasing demand for biopharmaceuticals is one of the major drivers in this market. The aging population in the US is expected to double and reach a total of 71 million by 2030. Cardiovascular diseases, Alzheimer's, and cancer are some of the most common diseases seen in the aged. Therefore, the steadily growing aging population increases the prevalence of these diseases, which in turn increases the demand for biopharmaceuticals. Further, the report states that the implementation of stringent regulations is one of the major challenges faced by the vendors in this market. Currently, the regulations for single-use bio-processing systems are not completely defined and documented, because the FDA has been quite liberal in not imposing more stringent regulations. However, the regulations are still uncertain owing to the limited usage of single-use bio-processing systems in commercial production. Key Vendors - GE Healthcare - Merck & Co Inc. - Sartorius Stedim Biotech SA - ThermoFisher Scientific Inc. Key Topics Covered: - Executive Summary - List of Abbreviations - Scope of the Report - Market Research Methodology - Introduction - Market Landscape - Market Segmentation by Applications - Geographical Segmentation - Buying Criteria - Market Growth Drivers - Drivers and their Impact - Market Challenges - Impact of Drivers and Challenges - Market Trends - Trends and their Impact - Vendor Landscape - Key Vendor Analysis For more information visit http://www.researchandmarkets.com/research/dk..._singleuse
MRK: 57.95 (+0.57)
